標(biāo)題: Titlebook: Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities; Awanish Mishra,Hitesh Kulhari Book 2023 The Editor(s) (i [打印本頁] 作者: Baleful 時間: 2025-3-21 18:52
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities影響因子(影響力)
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities影響因子(影響力)學(xué)科排名
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities網(wǎng)絡(luò)公開度
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities被引頻次
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities被引頻次學(xué)科排名
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities年度引用
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities年度引用學(xué)科排名
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities讀者反饋
書目名稱Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities讀者反饋學(xué)科排名
作者: JECT 時間: 2025-3-21 23:53
Nanocarriers as an Emerging Tool for Drug Delivery to Combat Neurodegenerative Diseaseseloping novel and efficacious delivery strategies to improve CNS disorders. Nanomedicines enable the drug delivery to penetrate the BBB and bind to the target regions without drug degradation. In the present chapter, we discussed the importance of nanocarriers such as liposomes, solid lipid nanopart作者: CRACK 時間: 2025-3-22 00:37 作者: lavish 時間: 2025-3-22 07:50
Pathophysiology and Management Approaches in Alzheimer’s Diseasefine the intricacies of the mechanism to facilitate the development of innovative strategies to tackle the progression of this disease. This chapter is orchestrated to elucidate the different aspects of the neuropathophysiological mechanisms underlying the development of Alzheimer’s disease and its 作者: 羊欄 時間: 2025-3-22 12:48 作者: 鞭子 時間: 2025-3-22 15:55
Pathophysiology and Management Approaches for Huntington’s Disease, Multiple Sclerosis, and Other Ne, and gliosis. Management strategies for MS mainly focuses on reducing the demyelination, inflammation by immunosuppressant or immunomodulators. But, some promising therapeutic approaches for management of MS such as BTK inhibitors, remyelination strategy are nowadays gaining attention and have show作者: 鞭子 時間: 2025-3-22 20:00
Genes Encoding Ion Channels in Neurotherapeutics: Opportunities and Challengesimprovement of the related neurological diseases with neurotherapeutics. Mutations can cause changes in the structure that conducts the opening and closing of the ion channel, changing the number of ion transitions. In this case, the implementation of a treatment is essential while there are still l作者: BANAL 時間: 2025-3-22 22:13
Herbal Approaches for the Management of Neurological Disordersay a crucial part of neuroprotective effect by means of several pharmacological action such as anti-inflammatory, antioxidant, antiapoptotic protection. So, they are promising natural neuroprotective agent to become as exceptional way for finding a novel candidate for the management of the neurologi作者: 開始發(fā)作 時間: 2025-3-23 01:34
Essential Considerations for Brain Delivery of Nanoformulationsloped and investigated for the improved delivery?of drugs?to the brain disorders. The effective delivery and penetration across the endothelial cells of brain can be achieved by considering various physiochemical factors of nanoparticles and of drugs while designing and formulation development. Addi作者: defray 時間: 2025-3-23 07:58 作者: 分期付款 時間: 2025-3-23 09:51 作者: 生銹 時間: 2025-3-23 16:23 作者: 爭議的蘋果 時間: 2025-3-23 21:15
Drug Delivery Strategies in Multiple Sclerosis, Huntington’s Disease and Other Neurodegenerative Disioning in normal and diseased situations are given. Overall, this chapter will collectively provide a summary of the recent advancements in bypassing the BBB via different approaches. We have also presented the critical overview of main challenges including challenges faced in designing of drug deli作者: 男生如果明白 時間: 2025-3-24 00:45
https://doi.org/10.1007/978-3-662-36243-3eloping novel and efficacious delivery strategies to improve CNS disorders. Nanomedicines enable the drug delivery to penetrate the BBB and bind to the target regions without drug degradation. In the present chapter, we discussed the importance of nanocarriers such as liposomes, solid lipid nanopart作者: 簡略 時間: 2025-3-24 04:46 作者: 開始從未 時間: 2025-3-24 09:20 作者: nephritis 時間: 2025-3-24 11:19 作者: 燕麥 時間: 2025-3-24 15:17 作者: Lipoprotein(A) 時間: 2025-3-24 20:26
https://doi.org/10.1007/978-3-662-36275-4improvement of the related neurological diseases with neurotherapeutics. Mutations can cause changes in the structure that conducts the opening and closing of the ion channel, changing the number of ion transitions. In this case, the implementation of a treatment is essential while there are still l作者: 爆米花 時間: 2025-3-24 23:42
Verzeichnis der K?fer Schlesiensay a crucial part of neuroprotective effect by means of several pharmacological action such as anti-inflammatory, antioxidant, antiapoptotic protection. So, they are promising natural neuroprotective agent to become as exceptional way for finding a novel candidate for the management of the neurologi作者: FISC 時間: 2025-3-25 06:56 作者: alcohol-abuse 時間: 2025-3-25 10:40
https://doi.org/10.1007/978-3-662-37803-8ators have also proven their efficacy in Alzheimer’s treatment. Such neuromodulators can be advantageous for the early staging of AD. Although various neuroprotective medicaments are available for the management of AD, but their efficacy is limited due to blood-brain barrier obstruction, high lipoph作者: magnanimity 時間: 2025-3-25 15:38 作者: omnibus 時間: 2025-3-25 18:19 作者: 運(yùn)動的我 時間: 2025-3-25 23:30 作者: Omnipotent 時間: 2025-3-26 04:02 作者: 搖曳的微光 時間: 2025-3-26 06:10
Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities978-981-99-6807-7作者: conifer 時間: 2025-3-26 08:46 作者: 有限 時間: 2025-3-26 13:45 作者: Hemiparesis 時間: 2025-3-26 20:51 作者: seroma 時間: 2025-3-26 22:06
https://doi.org/10.1007/978-3-662-36243-3ction, functional recovery, and improved outcomes. Through this comprehensive analysis, the chapter navigates the intricate journey from TBI’s molecular mechanisms to contemporary management paradigms, illuminating the multifaceted nature of addressing this critical neurological challenge.作者: Inflammation 時間: 2025-3-27 01:39
https://doi.org/10.1007/978-3-662-37803-8ting and penetration into the deepest brain regions as well as the protection of the encapsulated drug. Thus, in this chapter we explore the recent advances in the development of different controlled drug delivery systems for the management of epilepsy disorders.作者: TOM 時間: 2025-3-27 07:45
Pathophysiology and Management Approaches for Traumatic Brain Injuryction, functional recovery, and improved outcomes. Through this comprehensive analysis, the chapter navigates the intricate journey from TBI’s molecular mechanisms to contemporary management paradigms, illuminating the multifaceted nature of addressing this critical neurological challenge.作者: Diuretic 時間: 2025-3-27 12:27 作者: Suggestions 時間: 2025-3-27 16:24 作者: Armada 時間: 2025-3-27 18:02
https://doi.org/10.1007/978-3-662-36243-3rformed. In this chapter, drug management of ionic and neurotransmitter imbalances in epileptic seizures, the effect of vagus nerve stimulation on epileptic seizures, and the role of surgical operations in damping seizures will be discussed.作者: 流動才波動 時間: 2025-3-27 22:32
Transporter Systems and Metabolism at the Blood–Brain Barrier and Blood–CSF Barrierlighted physicochemical aspects of barriers and various drug transporting mechanisms across the BBB and B-CSF barriers.Besides, recent developments and future prospects of transporter systems in combating neurodegenerative diseases have also been discussed.作者: aqueduct 時間: 2025-3-28 04:53 作者: Meager 時間: 2025-3-28 06:20
https://doi.org/10.1007/978-981-99-6807-7Neurological Disorders; Pathophysiology; Drug Delivery; Nanotechnology; Herbal Bioactives作者: 臨時抱佛腳 時間: 2025-3-28 11:13 作者: ADORN 時間: 2025-3-28 17:42 作者: BOOM 時間: 2025-3-28 20:55
http://image.papertrans.cn/e/image/283038.jpg作者: Assemble 時間: 2025-3-28 23:05
https://doi.org/10.1007/978-3-662-36243-3ivery process. The BBB is a constituent of the neurovascular unit. It comprises neurons, astrocytes, microglia, a basement membrane, and a layer of microvascular endothelial cells around the brain that protect the same. It maintains the right ionic balance within the brain and blocks the substances 作者: Mirage 時間: 2025-3-29 04:04 作者: 歌曲 時間: 2025-3-29 08:50
https://doi.org/10.1007/978-3-662-36243-3dity and mortality. The presence of blood–cerebrospinal fluid (B-CSF) and blood–brain barrier (BBB) causes attenuation of site-specific delivery of therapeutic agents in neurodegenerative disorders. Since last decade, nanocarriers such as liposomes, nanoparticles (NPs), nano emulsions, dendrimers, a作者: Visual-Field 時間: 2025-3-29 12:50 作者: 生氣的邊緣 時間: 2025-3-29 17:38 作者: Gnrh670 時間: 2025-3-29 21:00
https://doi.org/10.1007/978-3-662-36243-3his imbalance is the alteration of excitatory and inhibitory neurotransmitter settings. In particular, the inhibition of GABA neurotransmitters during seizures does not occur, which is expected to occur in a healthy state of neurons. Another situation is that excitatory glutamate neurotransmitters c作者: 發(fā)出眩目光芒 時間: 2025-3-30 03:14
https://doi.org/10.1007/978-3-662-36243-3ge. This review outlines key mechanisms, including excitotoxicity, inflammation, oxidative stress, and disrupted blood-brain barrier integrity. Furthermore, it underscores the importance of tailored management approaches that encompass acute medical interventions, and various neuroprotective agents.作者: Aggrandize 時間: 2025-3-30 07:50
https://doi.org/10.1007/978-3-662-36275-4rative disease. The characteristic feature of HD is mutation in the HTT gene which is located on chromosome 4 which leads to expansion of CAG repeat, causing neurodegeneration of striatum and cortex of brain. Along with genetic predisposition other molecular mechanism such as excitotoxicity, dopamin作者: 不合 時間: 2025-3-30 12:07
https://doi.org/10.1007/978-3-662-36275-4rement performed by electroencephalography determines the coefficient of application of neurotherapy. Serious changes in electrical activity lead to the onset of diseases including epilepsy, Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Recent devices producing electric current o作者: uveitis 時間: 2025-3-30 16:27
Verzeichnis der K?fer Schlesiensty, which actively compromising human life worldwide. Even though, clinically acceptable effective agents for therapeutics are anyhow at present underlying. As a result, discovering the neuroprotective candidates along least side effects and more desirable effect to aid the well-being of patients is作者: FADE 時間: 2025-3-30 18:39
https://doi.org/10.1007/978-3-662-37803-8; their robust eviction transport systems protect the invasion of harmful substance to the brain. A majority of the therapeutic agents used in treatment of CNS related disorders such as Parkinson’s diseases (PD), Alzheimer’s diseases (AD), migraine, schizophrenia diseases, brain tumors, multiple scl作者: nurture 時間: 2025-3-30 22:31 作者: 考博 時間: 2025-3-31 01:05
https://doi.org/10.1007/978-3-662-37803-8rder observed in 1% of the population over 50. The neuropathological manifestations of PD include α-synuclein aggregation in the dopaminergic neurons, mitochondrial dysfunction, neuroinflammation, oxidative stress, blood-brain permeability, and epigenetics. In PD, delivering therapeutic moieties lik作者: 危機(jī) 時間: 2025-3-31 05:54 作者: 勾引 時間: 2025-3-31 10:22
